Literature DB >> 26619332

Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review.

Ioannis Konstantinidis1, Girish N Nadkarni2, Rabi Yacoub2, Aparna Saha3, Priya Simoes4, Chirag R Parikh5, Steven G Coca2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26619332     DOI： 10.1001/jamainternmed.2015.6102

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  37 in total

1.  A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; M Alan Brookhart; Jason P Fine; Gerardo Heiss; J Bradley Layton; Jennifer E Flythe
Journal:  Am J Kidney Dis       Date:  2018-04-10       Impact factor: 8.860

2.  Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era.

Authors:  Rohit Maini; David B Wong; Daniel Addison; Elizabeth Chiang; Steven D Weisbord; Hani Jneid
Journal:  J Am Soc Nephrol       Date:  2018-11-02       Impact factor: 10.121

3.  Introduction to Nephropharmacology for the Clinician: A New CJASN Series.

Authors:  Thomas D Nolin; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-16       Impact factor: 8.237

4.  Exclusion of Persons with Kidney Disease in Trials of Peripheral Artery Disease: A Systematic Review of Randomized Trials.

Authors:  Yumeng Wen; O Alison Potok; Xin Wei; Ishan Paranjpe; Lili Chan; Rakesh Malhotra; Steven Coca; Jagat Narula; Jeffrey W Olin; Girish N Nadkarni; Pranav S Garimella
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-30       Impact factor: 8.237

5.  Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints.

Authors:  Patrick Rossignol; Rajiv Agarwal; Bernard Canaud; Alan Charney; Gilles Chatellier; Jonathan C Craig; William C Cushman; Ronald T Gansevoort; Bengt Fellström; Dahlia Garza; Nicolas Guzman; Frank A Holtkamp; Gerard M London; Ziad A Massy; Alexandre Mebazaa; Peter G M Mol; Marc A Pfeffer; Yves Rosenberg; Luis M Ruilope; Jonathan Seltzer; Amil M Shah; Salim Shah; Bhupinder Singh; Bergur V Stefánsson; Norman Stockbridge; Wendy Gattis Stough; Kristian Thygesen; Michael Walsh; Christoph Wanner; David G Warnock; Christopher S Wilcox; Janet Wittes; Bertram Pitt; Aliza Thompson; Faiez Zannad
Journal:  Eur Heart J       Date:  2019-03-14       Impact factor: 29.983

6.  Outcomes After Transcatheter Mitral Valve Repair in Patients With Renal Disease.

Authors:  Binita Shah; Pedro A Villablanca; Sreekanth Vemulapalli; Pratik Manandhar; Nicholas S Amoroso; Muhamed Saric; Cezar Staniloae; Mathew R Williams
Journal:  Circ Cardiovasc Interv       Date:  2019-02       Impact factor: 6.546

7.  Exclusion of Patients With Kidney Disease From Cardiovascular Trials.

Authors:  Julie H Ishida; Kirsten L Johansen
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

Review 8.  Genomics in CKD: Is This the Path Forward?

Authors:  Girish N Nadkarni; Carol R Horowitz
Journal:  Adv Chronic Kidney Dis       Date:  2016-03       Impact factor: 3.620

9.  The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.

Authors:  Amber O Molnar; William Petrcich; Matthew A Weir; Amit X Garg; Michael Walsh; Manish M Sood
Journal:  Nephrol Dial Transplant       Date:  2020-05-01       Impact factor: 5.992

Review 10.  Intersection Between Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Luke J Laffin; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.